(From the April 2013 Issue of MedStat)
Sandra Kim, MD, has been named medical director of the Center for Pediatric and Adolescent Inflammatory Bowel Disease within the Division of Gastroenterology, Hepatology and Nutrition. She is also an associate professor of clinical pediatrics at the Ohio State University College of Medicine. Dr. Kim’s clinical and research interests focus on pediatric inflammatory bowel diseases (IBD), including adolescent transitioning and quality improvement in pediatric IBD and translational research investigating the bacterial and genetic influences in IBD. Her research has been funded by the NIH and the Crohn’s and Colitis Foundation of America (CCFA). She currently serves as Chair of Pediatric Affairs for CCFA nationally and is a member of the Executive Committee for the CCFA National Scientific Advisory Committee as well as the steering committees for the CCFA Pediatric IBD Research Network (PRO-KIIDS) and the IBD Exchange. In addition, she chairs the Clinical Practice committee and Adolescent Transitioning working group for ImproveCareNow, a national, multi-institution collaborative focusing on improving outcomes in IBD patients.